These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9603005)

  • 1. In vitro delivery of dexamethasone using hydroxyapatite reservoirs.
    Billotte WG; Bajpai PK
    Biomed Sci Instrum; 1997; 34():13-7. PubMed ID: 9603005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo dapsone release from hydroxyapatite reservoirs.
    Lasserre A; Berty S; Bajpai PK
    Biomed Sci Instrum; 1997; 33():149-54. PubMed ID: 9731351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameters of protein delivery using hydroxyapatite in simulated body fluid.
    Tscholl B; Billotte WG; Reed D; Smith S; Kreinbrink K; Bajpai PK
    Biomed Sci Instrum; 1997; 34():70-5. PubMed ID: 9603015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ceramic system for delivering interleukin-2.
    Smith SW; Billotte WG; Krane D; Sage K; Bajpai PK
    Biomed Sci Instrum; 1997; 34():65-9. PubMed ID: 9603014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel drug delivery system for osteomyelitis using porous hydroxyapatite blocks loaded by centrifugation.
    Itokazu M; Matsunaga T; Kumazawa S; Yang W
    J Appl Biomater; 1995; 6(3):167-9. PubMed ID: 7492806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyapatite ceramics for continuous delivery of heparin.
    Abrams L; Bajpai PK
    Biomed Sci Instrum; 1994; 30():169-74. PubMed ID: 7948632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel controlled local drug delivery system for inner ear disease.
    Paulson DP; Abuzeid W; Jiang H; Oe T; O'Malley BW; Li D
    Laryngoscope; 2008 Apr; 118(4):706-11. PubMed ID: 18182968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
    Loftsson T; Hreinsdóttir D; Stefánsson E
    J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility of steroid-HA delivery system using adult castrated rams as a model.
    Benghuzzi H; England B
    Biomed Sci Instrum; 2001; 37():275-80. PubMed ID: 11347402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
    Kim DH; Martin DC
    Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation and release of a hydrophobic drug from hydroxyapatite coated liposomes.
    Xu Q; Tanaka Y; Czernuszka JT
    Biomaterials; 2007 Jun; 28(16):2687-94. PubMed ID: 17331574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of nanohydroxyapatite microspheres for medical applications.
    Mateus AY; Barrias CC; Ribeiro C; Ferraz MP; Monteiro FJ
    J Biomed Mater Res A; 2008 Aug; 86(2):483-93. PubMed ID: 17975824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a ceramic device for the continuous local delivery of steroids.
    Zafirau W; Parker D; Billotte W; Bajpai PK
    Biomed Sci Instrum; 1996; 32():63-70. PubMed ID: 8672691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a hydroxyapatite ceramic matrix for the continuous delivery of coumadin.
    Mileti IF; Bajpai PK
    Biomed Sci Instrum; 1995; 31():177-82. PubMed ID: 7654958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged local antibiotics delivery from hydroxyapatite functionalised with cyclodextrin polymers.
    Leprêtre S; Chai F; Hornez JC; Vermet G; Neut C; Descamps M; Hildebrand HF; Martel B
    Biomaterials; 2009 Oct; 30(30):6086-93. PubMed ID: 19674778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release and characterization of chitosan films as dexamethasone carrier.
    Rodrigues LB; Leite HF; Yoshida MI; Saliba JB; Cunha AS; Faraco AA
    Int J Pharm; 2009 Feb; 368(1-2):1-6. PubMed ID: 18955123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanohydroxyapatite microspheres as delivery system for antibiotics: release kinetics, antimicrobial activity, and interaction with osteoblasts.
    Ferraz MP; Mateus AY; Sousa JC; Monteiro FJ
    J Biomed Mater Res A; 2007 Jun; 81(4):994-1004. PubMed ID: 17252559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
    Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
    Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biomineral-binding cyclodextrins for controlled drug delivery in the oral cavity.
    Liu XM; Lee HT; Reinhardt RA; Marky LA; Wang D
    J Control Release; 2007 Sep; 122(1):54-62. PubMed ID: 17673326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hydroxyapatite particulate debris on the production of cytokines and proteases in human fibroblasts.
    Ninomiya JT; Struve JA; Stelloh CT; Toth JM; Crosby KE
    J Orthop Res; 2001 Jul; 19(4):621-8. PubMed ID: 11518271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.